Study of Lenalidomide in Relapse/Refractory Waldenstrom Macroglobulinemia

计划入组 17 人 · 首次发布于 2014 年 11 月 27 日

Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia

计划入组 4 人 · 首次发布于 2013 年 1 月 30 日

Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia

计划入组 21 人 · 首次发布于 2018 年 4 月 24 日

Ibrutinib(Imbruvica)

C₂₅H₂₄N₆O₂

ImmunityBio's CD19 CAR-NK Therapy Achieves Complete Responses in Late-Stage Waldenstrom Macroglobulinemia

BeiGene's BGB-16673 Shows Promise in Blood Cancer Treatment with Projected $9M Revenue by 2037

CAR-T Therapies AT-19 and XYF-19 Show Promise in Treating B-Cell Lymphomas